Literature DB >> 10164059

Rational prescribing of antibacterials in hospitalised children.

J E Hoppe1.   

Abstract

The subject of this review is the rational prescribing of antimicrobial agents for the therapy of serious community-acquired infections in hospitalised infants and children. First, cost-containment strategies such as streamlining of antibacterial therapy, outpatient parenteral antibacterial therapy and sequential ('stepdown') therapy with parenteral followed by oral therapy are reviewed. In most of these areas, paediatric studies are scant or lacking. Then specific paediatric aspects of the choice of parenteral antibacterials such as penicillins, cephalosporins, aminoglycosides, macrolides and other agents are discussed. With particular reference to cost containment, rational treatment strategies for some serious bacterial infections such as meningitis, occult bacteraemia, endocarditis, osteomyelitis, arthritis, pyelonephritis, Lyme borreliosis (advanced stages) and pneumonia are proposed. In most of these disease, there is potential for cutting treatment costs and studies that compare these newer strategies with traditional treatment regimens are urgently needed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10164059     DOI: 10.2165/00019053-199610060-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  101 in total

Review 1.  Management of community-acquired bacterial pneumonia in hospitalized children.

Authors:  G E Schutze; R F Jacobs
Journal:  Pediatr Infect Dis J       Date:  1992-02       Impact factor: 2.129

Review 2.  [Recommendations for the treatment of infectious endocarditis].

Authors:  J Niebel
Journal:  Dtsch Med Wochenschr       Date:  1990-07-13       Impact factor: 0.628

Review 3.  Sequential therapy with intravenous and oral cephalosporins.

Authors:  R Janknegt; J W van der Meer
Journal:  J Antimicrob Chemother       Date:  1994-01       Impact factor: 5.790

Review 4.  Bacterial meningitis: recent advances in pathophysiology and treatment.

Authors:  A R Tunkel; B Wispelwey; W M Scheld
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

Review 5.  Once-daily aminoglycoside administration: new strategies for an old drug.

Authors:  J M Kovarik; I M Hoepelman; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

Review 6.  Teicoplanin: 10 years of clinical experience.

Authors:  M Trautmann; H Wiedeck; M Ruhnke; M Oethinger; R Marre
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

Review 7.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Authors:  I R Friedland; G H McCracken
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

Review 8.  Infective endocarditis in children.

Authors:  R S Baltimore
Journal:  Pediatr Infect Dis J       Date:  1992-11       Impact factor: 2.129

Review 9.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

Authors:  W A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

Review 10.  Teicoplanin or vancomycin in the treatment of gram-positive infections?

Authors:  S Murphy; R J Pinney
Journal:  J Clin Pharm Ther       Date:  1995-02       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.